Vol.66 No.5 September 2018

Goals and strategies of the National Action Plan on Antimicrobial Resistance (AMR) in Japan

Norio Ohmagari

Jpn. J. Chemother. 66 (5): 558-566, 2018

In vitro antimicrobial activity of ceftolozane/tazobactam against clinical isolates from Japan

Yusuke Hidaka, Naoko Kishi, Satoru Matsumoto, Tomoko Yoshinari and Masahiko Mori

Jpn. J. Chemother. 66 (5): 567-577, 2018

Impact of pharmacist support on quality of care and clinical outcome in Staphylococcus aureus bacteremia

Dai Tanaka, Tomoyuki Osumi, Yosuke Inaba, Miyako Shibahara, Yoshihiro Suidou, Noboru Yoshimoto and Yasuhiro Kiko

Jpn. J. Chemother. 66 (5): 578-586, 2018

Evaluation of the efficacy of pharmacist-driven support for infectious diseases through an antimicrobial stewardship program for Staphylococcus aureus bacteremia

Masaru Samura, Naoki Hirose, Takenori Kurata, Junichi Ishii, Fumio Nagumo, Keisuke Takada, Sakura Koshioka, Masaki Uchida, Syunya Yamamoto, Junki Inoue, Hisakazu Sekine, Akira Ishida, Norifumi Kunika and Hiroyuki Kunishima

Jpn. J. Chemother. 66 (5): 587-599, 2018

Efficacy and safety of fluconazole in infants including neonates a special drug use-results survey

Koichi Murata, Junichi Oshima, Noriko Sugiyama, Hiroyuki Houzawa, Yukie Watanabe and Naomi Sugimoto

Jpn. J. Chemother. 66 (5): 600-609, 2018